BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25424463)

  • 1. Improvement of common cold with Pycnogenol®: a Winter registry study.
    Belcaro G; Shu H; Luzzi R; Dugall M; Ippolito E; Cesarone MR; Corsi M; Feragalli B
    Panminerva Med; 2014; 56(4):301-8. PubMed ID: 25424463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement in signs and symptoms in psoriasis patients with Pycnogenol® supplementation.
    Belcaro G; Luzzi R; Hu S; Cesarone MR; Dugall M; Ippolito E; Corsi M; Caporale S
    Panminerva Med; 2014 Mar; 56(1):41-8. PubMed ID: 24637472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pycnogenol® in postpartum symptomatic hemorrhoids.
    Belcaro G; Gizzi G; Pellegrini L; Dugall M; Luzzi R; Corsi M; Ippolito E; Ricci A; Cesarone MR; Ledda A; Bottari A; Errichi BM
    Minerva Ginecol; 2014 Feb; 66(1):77-84. PubMed ID: 24569406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrence of retinal vein thrombosis with Pycnogenol® or Aspirin® supplementation: a registry study.
    Rodriguez P; Belcaro G; Dugall M; Hu S; Luzzi R; Ledda A; Ippolito E; Corsi M; Ricci A; Feragalli B; Cornelli U; Gizzi C; Hosoi M
    Panminerva Med; 2015 Sep; 57(3):121-5. PubMed ID: 25971329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement in symptoms and cochlear flow with pycnogenol in patients with Meniere's disease and tinnitus.
    Luzzi R; Belcaro G; Hu S; Dugall M; Hosoi M; Cacchio M; Ippolito E; Corsi M
    Minerva Med; 2014 Jun; 105(3):245-54. PubMed ID: 24988090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The COFU3 Study. Improvement in cognitive function, attention, mental performance with Pycnogenol® in healthy subjects (55-70) with high oxidative stress.
    Belcaro G; Dugall M; Ippolito E; Hu S; Saggino A; Feragalli B
    J Neurosurg Sci; 2015 Dec; 59(4):437-46. PubMed ID: 26635191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pycnogenol® improvements in asthma management.
    Belcaro G; Luzzi R; Cesinaro Di Rocco P; Cesarone MR; Dugall M; Feragalli B; Errichi BM; Ippolito E; Grossi MG; Hosoi M; Errichi S; Cornelli U; Ledda A; Gizzi G
    Panminerva Med; 2011 Sep; 53(3 Suppl 1):57-64. PubMed ID: 22108478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pycnogenol® supplementation to relieve symptoms after hemorrhoidectomy.
    Belcaro G; Cotellese R; Corsi M; Cesarone MR; Scipione C; Scipione V; Cornelli U; Ippolito E; Dugall M; Hosoi M; Feragalli B
    Minerva Surg; 2024 Jun; 79(3):309-314. PubMed ID: 38847768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of post thrombotic syndrome with Pycnogenol® in a twelve month study.
    Errichi BM; Belcaro G; Hosoi M; Cesarone MR; Dugall M; Feragalli B; Bavera P; Hosoi M; Zulli C; Corsi M; Ledda A; Luzzi R; Ricci A
    Panminerva Med; 2011 Sep; 53(3 Suppl 1):21-7. PubMed ID: 22108473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention and control of jet lag symptoms and temporary impairment of cognitive function with Pycnogenol® in healthy individuals and in hypertensives.
    Belcaro G; Hu S; Hosoi M; Cesarone MR; Ledda A; Dugall M; Cornelli U; Saggino A; Cotellese R; Feragalli B; Cox D; Peterzan P; Scipione C; Scipione V
    Minerva Med; 2024 Apr; 115(2):178-184. PubMed ID: 38197571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pycnogenol® improves cognitive function, attention, mental performance and specific professional skills in healthy professionals aged 35-55.
    Belcaro G; Luzzi R; Dugall M; Ippolito E; Saggino A
    J Neurosurg Sci; 2014 Dec; 58(4):239-48. PubMed ID: 24675223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the effects of supplementation with Pycnogenol® on fitness in normal subjects with the Army Physical Fitness Test and in performances of athletes in the 100-minute triathlon.
    Vinciguerra G; Belcaro G; Bonanni E; Cesarone MR; Rotondi V; Ledda A; Hosoi M; Dugall M; Cacchio M; Cornelli U
    J Sports Med Phys Fitness; 2013 Dec; 53(6):644-54. PubMed ID: 24247188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supplementary management with Pycnogenol® in patients with lupus vasculitis in remission phases: a pilot, concept registry study.
    Cesarone MR; Belcaro G; Corsi M; Scipione C; Scipione V; Hu S; Hosoi M; Ledda A; Feragalli B; Cotellese R
    Minerva Cardioangiol; 2020 Apr; 68(2):146-152. PubMed ID: 32429631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiopathic myalgic pain (fibromyalgia): supportive management and prevention with Pycnogenol®.
    Belcaro G; Hu S; Cesarone MR; Dugall M; Scipione C; Scipione V; Hosoi M; Ledda A; Cornelli U; Feragalli B; Cotellese R
    Panminerva Med; 2021 Mar; 63(1):46-50. PubMed ID: 33541059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Episodic primary migraine headache: supplementary prophylaxis with Pycnogenol® prevents attacks and controls oxidative stress.
    Cesarone MR; Dugall M; Hu S; Belcaro G; Hosoi M; Scipione V; Scipione C; Cotellese R
    Panminerva Med; 2020 Jun; 62(2):102-108. PubMed ID: 31670494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supplementation with Pycnogenol® improves signs and symptoms of menopausal transition.
    Errichi S; Bottari A; Belcaro G; Cesarone MR; Hosoi M; Cornelli U; Dugall M; Ledda A; Feragalli B
    Panminerva Med; 2011 Sep; 53(3 Suppl 1):65-70. PubMed ID: 22108479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pycnogenol® and Centella asiatica in the management of asymptomatic atherosclerosis progression.
    Belcaro G; Ippolito E; Dugall M; Hosoi M; Cornelli U; Ledda A; Scoccianti M; Steigerwalt RD; Cesarone MR; Pellegrini L; Luzzi R; Corsi M
    Int Angiol; 2015 Apr; 34(2):150-7. PubMed ID: 25519846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pycnogenol® supplementation in minimal cognitive dysfunction.
    Hosoi M; Belcaro G; Saggino A; Luzzi R; Dugall M; Feragalli B
    J Neurosurg Sci; 2018 Jun; 62(3):279-284. PubMed ID: 29754480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventive effects of Pycnogenol® on cardiovascular risk factors (including endothelial function) and microcirculation in subjects recovering from coronavirus disease 2019 (COVID-19).
    Belcaro G; Cornelli U; Cesarone MR; Scipione C; Scipione V; Hu S; Feragalli B; Corsi M; Cox D; Cotellese R; Hosoi M; Burki C
    Minerva Med; 2022 Apr; 113(2):300-308. PubMed ID: 34060731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behçet syndrome: effects of Pycnogenol® supplementation during regression phases.
    Hu S; Belcaro G; Ledda A; Corsi M; Cotellese R; Feragalli B; Hosoi M; Dugall M; Torino-Rodriguez P; Cesarone MR
    Minerva Cardioangiol; 2018 Aug; 66(4):386-390. PubMed ID: 29975020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.